Dashboard
Portfolios
Watchlist
Community
Discover
Screener
NE
neofeudal
Community Contributor
Followers
12
Total number of followers
Comments
1
Total number of comments
Member Since
2021
Date joined
No bio added yet
No link added
Coherus Oncology
NE
neofeudal
Community Contributor
Coherus BioSciences will see 16% revenue growth driving future value
Coherus is a promising company that did a bad borrowing and has more than paid the price. Its convertible bondholders created a short hedge and have inflicted massive damage on the company's SP.
View narrative
US$15.42
FV
94.3% undervalued
intrinsic discount
16.00%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
5 months ago
author updated this narrative